2026 data Public-data reference. official source

Dialyzer, Capillary, Hollow Fiber

Open-data reference.

FDA MAUDE adverse event data · 1992–2026

What the Data Shows About Dialyzer, Capillary, Hollow Fiber

The FDA MAUDE database aggregates 8,369 adverse-event reports for Dialyzer, Capillary, Hollow Fiber spanning the period from 1992 through 2026. Of these, 157 are classified as death reports, 3,159 as injury reports, and 4,605 as malfunction reports under FDA adverse-event categorization rules. Report counts do not by themselves indicate a device is unsafe — widely used devices and longer market histories naturally generate larger raw counts, so proportional and comparative reads are more informative than totals alone.

The adverse-event profile breaks down across 5 distinct event types and 14 reported patient-outcome categories, giving a multi-dimensional view that goes beyond a single headline number. A total of 17 distinct product-problem codes appear in the reports, with Fluid/Blood Leak topping the list at 815 reports. Reports are associated with 10 different manufacturers in the MAUDE record, reflecting both OEMs and repackagers of this device category.

Annual reporting volume is tracked across 35 years of MAUDE data, with the peak single-year volume reaching 1,522 reports — trend shape often reflects changes in device adoption, reporting rules, or FDA enforcement focus rather than underlying device behavior alone. Events are documented across 15 reported care-setting categories (hospital, home, ambulatory surgery center, etc.). All figures reflect the openFDA MAUDE snapshot last refreshed on . This page is informational and is not medical advice — discuss device-safety questions with your healthcare provider.

8,369
Total Reports
157
Death Reports
3,159
Injury Reports
4,605
Malfunctions

Event Types

Malfunction 4,605 (55.0%)
Injury 3,159 (37.7%)
Other 370 (4.4%)
Death 157 (1.9%)
78 (0.9%)

Patient Outcomes

4,652 (52.0%)
Required Intervention 2,366 (26.5%)
Other 778 (8.7%)
Hospitalization 339 (3.8%)
R 304 (3.4%)
Death 155 (1.7%)
L 135 (1.5%)
O 100 (1.1%)
Life Threatening 75 (0.8%)
H 17 (0.2%)
S 11 (0.1%)
Congenital Anomaly 9 (0.1%)
Disability 2 (0.0%)
Invalid Data 1 (0.0%)

Top Product Problems

Fluid/Blood Leak 815
Adverse Event Without Identified Device or Use Problem 309
Break 32
Device Contamination with Chemical or Other Material 23
Crack 17
Occlusion Within Device 13
Leak/Splash 5
Loose or Intermittent Connection 2
Air/Gas in Device 1
Complete Blockage 1
Connection Problem 1
Contamination 1
Device Issue 1
Material Rupture 1
No Flow 1
Patient-Device Incompatibility 1
Use of Device Problem 1

Yearly Trend

92
1992: 19
93
1993: 30
94
1994: 206
95
1995: 136
96
1996: 1,522
97
1997: 340
98
1998: 440
99
1999: 465
00
2000: 559
01
2001: 504
02
2002: 273
03
2003: 183
04
2004: 201
05
2005: 157
06
2006: 91
07
2007: 17
08
2008: 11
09
2009: 3
10
2010: 32
11
2011: 47
12
2012: 211
13
2013: 553
14
2014: 633
15
2015: 561
16
2016: 562
17
2017: 182
18
2018: 11
19
2019: 20
20
2020: 16
21
2021: 12
22
2022: 2
23
2023: 51
24
2024: 152
25
2025: 145
26
2026: 22

Related Entities for Dialyzer, Capillary, Hollow Fiber

Event Locations

4,612 (55.1%)
OUTPATIENT TREATMENT FACILITY 1,965 (23.5%)
I 880 (10.5%)
NO INFORMATION 247 (3.0%)
INVALID DATA 235 (2.8%)
HOSPITAL 217 (2.6%)
OTHER 129 (1.5%)
DIALYSIS CENTER 32 (0.4%)
UNKNOWN 20 (0.2%)
DIALYSIS UNIT 10 (0.1%)
HOME 10 (0.1%)
OUTPATIENT DIAGNOSTIC FACILITY 8 (0.1%)
NURSING HOME 2 (0.0%)
AMBULATORY SURGICAL FACILITY 1 (0.0%)
NOT APPLICABLE 1 (0.0%)

Compare FRESENIUS MEDICAL CARE NORTH AMERICA vs NISSHO →

Data Source

FDA Manufacturer and User Facility Device Experience (MAUDE) database via the openFDA API. Reports are submitted by manufacturers, healthcare facilities, and patients. Report counts do not indicate a device is unsafe — higher-use devices naturally generate more reports.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the FDA MAUDE database. Consult a qualified professional before making decisions based on this data.